Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses. (Q38403431)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 April 2017

Language	Label	Description	Also known as
English	Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.	scientific article published on 29 April 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28456941%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28456941%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

experimental autoimmune encephalomyelitis

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28456941%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Chi-Ho Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28456941%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Se Jin Jeon

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28456941%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Kyu Suk Cho

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28456941%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Eunjung Moon

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28456941%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Arjun Sapkota

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28456941%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Jong Hoon Ryu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28456941%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Ji Woong Choi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28456941%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

29 April 2017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28456941%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Molecular Neurobiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28456941%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

55

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28456941%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28456941%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

3007-3020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28456941%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Mutated recombinant human glucagon-like peptide-1 protects SH-SY5Y cells from apoptosis induced by amyloid-beta peptide (1-42).

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Glucagon-like peptide-1 inhibits LPS-induced IL-1beta production in cultured rat astrocytes.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Exendin-4 reverts behavioural and neurochemical dysfunction in a pre-motor rodent model of Parkinson's disease with noradrenergic deficit

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Exendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Exendin-4 ameliorates traumatic brain injury-induced cognitive impairment in rats

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Exendin-4 protects dopaminergic neurons by inhibition of microglial activation and matrix metalloproteinase-3 expression in an animal model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Reversible neural stem cell niche dysfunction in a model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Inhibition of autoimmune encephalomyelitis by a tetracycline.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Fingolimod modulates microglial activation to augment markers of remyelination

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

GLP-1 secretion by microglial cells and decreased CNS expression in obesity.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Exendin-4 reduces ischemic brain injury in normal and aged type 2 diabetic mice and promotes microglial M2 polarization

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Exendin-4 treatment improves metabolic control after rat islet transplantation to athymic mice with streptozotocin-induced diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Neuroprotective effect of 6-paradol in focal cerebral ischemia involves the attenuation of neuroinflammatory responses in activated microglia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Nuclear factor kappa B (NF-κB) in multiple sclerosis pathology

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

The complexity of NF-κB signaling in inflammation and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

The role of hyperglycemia in acute stroke

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

The DPP-4 inhibitor linagliptin counteracts stroke in the normal and diabetic mouse brain: a comparison with glimepiride

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Ischemia-induced changes in glucagon-like peptide-1 receptor and neuroprotective effect of its agonist, exendin-4, in experimental transient cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Exendin-4 improves steatohepatitis by increasing Sirt1 expression in high-fat diet-induced obese C57BL/6J mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

FTY720 rescue therapy in the dark agouti rat model of experimental autoimmune encephalomyelitis: expression of central nervous system genes and reversal of blood-brain-barrier damage

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Glucagon-like peptide-1 protects synaptic and learning functions from neuroinflammation in rodents.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

The type 2 diabetes drug liraglutide reduces chronic inflammation induced by irradiation in the mouse brain.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Exendin-4 Inhibits Matrix Metalloproteinase-9 Activation and Reduces Infarct Growth After Focal Cerebral Ischemia in Hyperglycemic Mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Bipolar/rod-shaped microglia are proliferating microglia with distinct M1/M2 phenotypes.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Microglia express distinct M1 and M2 phenotypic markers in the postnatal and adult central nervous system in male and female mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Selective modulation of microglia polarization to M2 phenotype for stroke treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Microglial cell activation and proliferation precedes the onset of CNS autoimmunity

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Amelioration of experimental autoimmune encephalomyelitis by plumbagin through down-regulation of JAK-STAT and NF-κB signaling pathways

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Preventive and therapeutic effects of adenanthin on experimental autoimmune encephalomyelitis by inhibiting NF-κB signaling

1 reference

https://api.crossref.org/works/10.1007%2FS12035-017-0550-2

21 January 2018

Activation of spinal glucagon-like peptide-1 receptors specifically suppresses pain hypersensitivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/28456941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The genetics of multiple sclerosis: review of current and emerging candidates

1 reference

https://pubmed.ncbi.nlm.nih.gov/28456941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/28456941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study

1 reference

https://pubmed.ncbi.nlm.nih.gov/28456941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Animal Models of MS Reveal Multiple Roles of Microglia in Disease Pathogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/28456941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/28456941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse

1 reference

https://pubmed.ncbi.nlm.nih.gov/28456941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased glucagon-like peptide-1 receptor expression in glia after mechanical lesion of the rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/28456941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Induction of cytomixis affects microsporogenesis in Sesamum indicum L. (Pedaliaceae)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/28456941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/28456941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/28456941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control

1 reference

https://pubmed.ncbi.nlm.nih.gov/28456941

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38403431&oldid=2201663367"